v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 35,469 $ 30,014
Restricted cash 742 15,466
Accounts receivable, net of allowance for credit losses of $23 and $85, respectively 58,217 58,729
Inventories 49,914 52,611
Derivative instruments 3,313 2,412
Other current assets 5,463 9,538
Total current assets 153,118 168,770
Property and equipment, net 214,742 248,748
Other Assets:    
Right of use operating lease assets, net 20,553 22,597
Intangible assets, net 4,509 8,498
Other assets 8,516 5,628
Total other assets 33,578 36,723
Total Assets 401,438 454,241
Current Liabilities:    
Accounts payable 20,369 20,752
Accrued liabilities 24,214 20,205
Current portion – operating leases 4,851 4,333
Derivative instruments 1,177 13,849
Other current liabilities 7,193 6,149
Total current liabilities 57,804 65,288
Long-term debt, net 92,904 82,097
Operating leases, net of current portion 16,913 19,029
Other liabilities 8,754 8,270
Total Liabilities 176,375 174,684
Commitments and contingencies (Notes 1, 8, 9, 10 and 14)
Stockholders’ Equity:    
Preferred stock, value
Common stock, value 77 76
Additional paid-in capital 1,044,176 1,040,912
Accumulated other comprehensive income 4,975 2,481
Accumulated deficit (824,166) (763,913)
Total stockholders’ equity 225,063 279,557
Total Liabilities and Stockholders’ Equity 401,438 454,241
Series A Preferred Stock    
Stockholders’ Equity:    
Preferred stock, value
Series B Preferred Stock    
Stockholders’ Equity:    
Preferred stock, value 1 1
Non-voting common stock    
Stockholders’ Equity:    
Common stock, value

Source